A novel likely pathogenic heterozygous HECW2 missense variant in a family with variable expressivity of neurodevelopmental delay, hypotonia, and epileptiform EEG patterns.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
12 2021
Historique:
revised: 08 06 2021
received: 02 01 2021
accepted: 25 06 2021
pubmed: 31 7 2021
medline: 3 3 2022
entrez: 30 7 2021
Statut: ppublish

Résumé

Pathogenic variants in HECW2 are extremely rare. So far, only 19 cases have been reported. They were associated with epilepsy, intellectual disability, absent language, hypotonia, and autism. As these cases were all de novo mutations, mostly presenting without identical variants, variable expressivity has never been investigated. Here, we describe the first family with the same novel variant in HECW2. A 19-year old female patient presented with bursts of generalized spike-wave discharges and intellectual disability. We performed next-generation-sequencing, to detect the genetic cause. Next-generation-sequencing revealed a novel likely pathogenic variant in HECW2 (c.3571C>T; p.Arg1191Trp) in the index patient, her mother and brother. They showed some similar phenotypic patterns with intellectual disability, hypotonia and generalized epileptiform patterns. However, the mother was less severely affected and epileptiform patterns were less frequent. The brother presented with additional autistic features. In contrast to previous cases, the speech of all individuals was only mildly impaired. This is the first case report of a family with the same novel likely pathogenic variant in HECW2 and as such provides insight into the phenotypic variability of this mutation. The expressivity of symptoms may be so mild that genetic and EEG analysis are needed to disclose the correct diagnosis.

Identifiants

pubmed: 34327820
doi: 10.1002/ajmg.a.62427
doi:

Substances chimiques

HECW2 protein, human EC 2.3.2.26
Ubiquitin-Protein Ligases EC 2.3.2.27

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

3838-3843

Informations de copyright

© 2021 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.

Références

Appenzeller, S., Balling, R., Barisic, N., Baulac, S., Caglayan, H., Craiu, D., De Jonghe, P., Depienne, C., Dimova, P., Djémié, T., Gormley, P., Guerrini, R., Helbig, I., Hjalgrim, H., Hoffman-Zacharska, D., Jähn, J., Klein, K. M., Koeleman, B., Komarek, V., … Sherr, E. (2014). De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. American Journal of Human Genetics, 95(4), 360-370. https://doi.org/10.1016/j.ajhg.2014.08.013
Berko, E. R., Cho, M. T., Eng, C., Shao, Y., Sweetser, D. A., Waxler, J., Robin, N. H., Brewer, F., Donkervoort, S., Mohassel, P., Bönnemann, C. G., Bialer, M., Moore, C., Wolfe, L. A., Tifft, C. J., Shen, Y., Retterer, K., Millan, F., & Chung, W. K. (2017). De novo missense variants in HECW2 are associated with neurodevelopmental delay and hypotonia. Journal of Medical Genetics, 54(2), 84-86. https://doi.org/10.1136/jmedgenet-2016-103943
Brown, S. D. M., & Moore, M. W. (2012). The international mouse phenotyping consortium: Past and future perspectives on mouse phenotyping. Mammalian Genome: Official Journal of the International Mammalian Genome Society, 23(9-10), 632-640. https://doi.org/10.1007/s00335-012-9427-x
Halvardson, J., Zhao, J. J., Zaghlool, A., Wentzel, C., Georgii-Hemming, P., Månsson, E., Ederth Sävmarker, H., Brandberg, G., Soussi Zander, C., Thuresson, A. C., & Feuk, L. (2016). Mutations in HECW2 are associated with intellectual disability and epilepsy. Journal of Medical Genetics, 53(10), 697-704. https://doi.org/10.1136/jmedgenet-2016-103814
Iossifov, I., O'Roak, B. J., Sanders, S. J., Ronemus, M., Krumm, N., Levy, D., Stessman, H. A., Witherspoon, K. T., Vives, L., Patterson, K. E., Smith, J. D., Paeper, B., Nickerson, D. A., Dea, J., Dong, S., Gonzalez, L. E., Mandell, J. D., Mane, S. M., Murtha, M. T., … Wigler, M. (2014). The contribution of de novo coding mutations to autism spectrum disorder. Nature, 515(7526), 216-221. https://doi.org/10.1038/nature13908
Killick, R., Niklison-Chirou, M., Tomasini, R., Bano, D., Rufini, A., Grespi, F., Velletri, T., Tucci, P., Sayan, B. S., Conforti, F., Gallagher, E., Nicotera, P., Mak, T. W., Melino, G., Knight, R. A., & Agostini, M. (2011). p73: A multifunctional protein in neurobiology. Molecular Neurobiology, 43(2), 139-146. https://doi.org/10.1007/s12035-011-8172-6
Krumm, N., Turner, T. N., Baker, C., Vives, L., Mohajeri, K., Witherspoon, K., Raja, A., Coe, B. P., Stessman, H. A., He, Z. X., Leal, S. M., Bernier, R., & Eichler, E. E. (2015). Excess of rare, inherited truncating mutations in autism. Nature Genetics, 47(6), 582-588. https://doi.org/10.1038/ng.3303
Li, H., & Durbin, R. (2010). Fast and accurate long-read alignment with burrows-wheeler transform. Bioinformatics (Oxford, England), 26(5), 589-595. https://doi.org/10.1093/bioinformatics/btp698
Lu, L., Hu, S., Wei, R., Qiu, X., Lu, K., Fu, Y., Li, H., Xing, G., Li, D., Peng, R., He, F., & Zhang, L. (2013). The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation maintains the metaphase to anaphase transition. The Journal of Biological Chemistry, 288(50), 35637-35650. https://doi.org/10.1074/jbc.M113.472076
Marian, A. J., & Roberts, R. (2001). The molecular genetic basis for hypertrophic cardiomyopathy. Journal of Molecular and Cellular Cardiology, 33(4), 655-670. https://doi.org/10.1006/jmcc.2001.1340
McRae, J. F., Clayton, S., Fitzgerald, T. W., Kaplanis, J., Prigmore, E., Rajan, D., Sifrim, A., Aitken, S., Akawi, N., Alvi, M., Ambridge, K., Barrett, D. M., Bayzetinova, T., Jones, P., Jones, W. D., King, D., Krishnappa, N., Mason, L. E., Singh, T., … Hurles, M. E. (2017). Prevalence and architecture of de novo mutations in developmental disorders. Nature, 542(7642), 433-438. https://doi.org/10.1038/nature21062
Miyazaki, K., Ozaki, T., Kato, C., Hanamoto, T., Fujita, T., Irino, S., Watanabe, K., Nakagawa, T., & Nakagawara, A. (2003). A novel HECT-type E3 ubiquitin ligase, NEDL2, stabilizes p73 and enhances its transcriptional activity. Biochemical and Biophysical Research Communications, 308(1), 106-113. https://doi.org/10.1016/S0006-291X(03)01347-0
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., Voelkerding, K., Rehm, H. L., & ACMG Laboratory Quality Assurance Committee. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 17(5), 405-424. https://doi.org/10.1038/gim.2015.30
Rotin, D., & Kumar, S. (2009). Physiological functions of the HECT family of ubiquitin ligases. Nature Reviews. Molecular Cell Biology, 10(6), 398-409. https://doi.org/10.1038/nrm2690
Ullman, N. L., Smith-Hicks, C. L., Desai, S., & Stafstrom, C. E. (2018). De novo HECW2 mutation associated with epilepsy, developmental decline, and intellectual disability: Case report and review of literature. Pediatric Neurology, 85, 76-78. https://doi.org/10.1016/j.pediatrneurol.2018.03.005
Wright, C. F., Fitzgerald, T. W., Jones, W. D., Clayton, S., McRae, J. F., van Kogelenberg, M., King, D. A., Ambridge, K., Barrett, D. M., Bayzetinova, T., Bevan, A. P., Bragin, E., Chatzimichali, E. A., Gribble, S., Jones, P., Krishnappa, N., Mason, L. E., Miller, R., Morley, K. I., … DDD study. (2015). Genetic diagnosis of developmental disorders in the DDD study: A scalable analysis of genome-wide research data. The Lancet, 385(9975), 1305-1314. https://doi.org/10.1016/S0140-6736(14)61705-0

Auteurs

Ev-Christin Heide (EC)

Department of Neurology, University Medical Center, Georg-August University, Göttingen, Germany.

Oliver Puk (O)

Praxis für Humangenetik Tübingen, Tübingen, Germany.

Saskia Biskup (S)

Praxis für Humangenetik Tübingen, Tübingen, Germany.
CeGaT GmbH, Tübingen, Germany.

Arne Krahn (A)

Department of Neurology, University Medical Center, Georg-August University, Göttingen, Germany.

Erik Rauf (E)

Department of Neurology, University Medical Center, Georg-August University, Göttingen, Germany.

Barbara A K Kreilkamp (BAK)

Department of Neurology, University Medical Center, Georg-August University, Göttingen, Germany.
Department of Pharmacology & Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.

Walter Paulus (W)

Department of Clinical Neurophysiology, University Medical Center, Georg-August University, Göttingen, Germany.

Niels K Focke (NK)

Department of Neurology, University Medical Center, Georg-August University, Göttingen, Germany.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH